capital raising, page-19

re: genelabs sale
contacted the company today and got a prompt reply ...

they say they don't anticipate, and have not been advised that the Genelabs Diagnostics sale will in any way affect select ... they say sale had been mooted for some time ... point also made that the involvement of a large diagnostics company like MP Biomedicals in the Genelabs Diagnostics business would be a good thing with the possibility of extra resources etc.

so, as always, if you believe in the product - and given the burnett institute's reputation there's no reason not to - then select is a bit behind in its timeline, but ready to push ahead with its various revenue generating deals.